Allspring Global Investments’s abrdn Life Sciences Investors HQL Stock Holding History

Allspring Global Investments’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.9M	Buy	362,535 +132,098	+57%	+$2.21M	0.01%	829
2025 Q4	$3.87M	Sell	230,437 -5,062	-2%	-$85.1K	0.01%	906
2025 Q3	$3.65M	Hold	235,499	–	–	0.01%	923
2025 Q2	$3.02M	Buy	235,499 +42,015	+22%	+$518K	0.01%	973
2025 Q1	$2.46M	Buy	193,484 +27,433	+17%	+$371K	﹤0.01%	1060
2024 Q4	$2.18M	Sell	166,051 -114,251	-41%	-$1.65M	﹤0.01%	1128
2024 Q3	$4.23M	Sell	280,302 -66,319	-19%	-$1M	0.01%	993
2024 Q2	$4.91M	Sell	346,621 -84,699	-20%	-$1.15M	0.01%	956
2024 Q1	$5.88M	Sell	431,320 -22,834	-5%	-$316K	0.01%	915
2023 Q4	$6.11M	Buy	454,154 +106,539	+31%	+$1.31M	0.01%	894
2023 Q3	$4.33M	Buy	347,615 +38,000	+12%	+$500K	0.01%	1006
2023 Q2	$4.19M	Buy	309,615 +91,010	+42%	+$1.26M	0.01%	1044
2023 Q1	$3.05M	Buy	218,605 +62,721	+40%	+$897K	0.01%	1127
2022 Q4	$2.22M	Buy	+155,884	New	+$2.26M	﹤0.01%	1209

Other funds holding HQL

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

Allspring Global Investments's HQL Position: Q1 2026 in Review

Allspring Global Investments increased its abrdn Life Sciences Investors (HQL) stake by 57% in Q1 2026, buying an estimated $2.21M and bringing the position to 362,535 shares worth $5.9M. The position accounts for 0.01% of the portfolio, ranked #829.

Allspring Global Investments first reported a position in HQL in Q4 2022 and has held it in 14 quarters since. The position peaked at $6.11M in Q4 2023. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

Allspring Global Investments held 362,535 shares of abrdn Life Sciences Investors worth $5.9M as of Q1 2026.
Allspring Global Investments bought 132,098 abrdn Life Sciences Investors shares in Q1 2026, an estimated $2.21M.
abrdn Life Sciences Investors made up 0.01% of Allspring Global Investments's portfolio in Q1 2026, its #829 holding.
Allspring Global Investments first reported a position in abrdn Life Sciences Investors in Q4 2022 and has held it in 14 quarters since.
Allspring Global Investments's abrdn Life Sciences Investors position peaked at $6.11M in Q4 2023.
86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.